Federico Turkheimer

ORCID: 0000-0002-3766-3815
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Functional Brain Connectivity Studies
  • Advanced MRI Techniques and Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroscience and Neuropharmacology Research
  • Advanced Neuroimaging Techniques and Applications
  • Neural dynamics and brain function
  • Tryptophan and brain disorders
  • Alzheimer's disease research and treatments
  • Radiopharmaceutical Chemistry and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Neurological disorders and treatments
  • Schizophrenia research and treatment
  • Parkinson's Disease Mechanisms and Treatments
  • Neurotransmitter Receptor Influence on Behavior
  • Lanthanide and Transition Metal Complexes
  • Glioma Diagnosis and Treatment
  • Stress Responses and Cortisol
  • Multiple Sclerosis Research Studies
  • S100 Proteins and Annexins
  • Dementia and Cognitive Impairment Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Medical Image Segmentation Techniques
  • Mitochondrial Function and Pathology
  • Neurological Disease Mechanisms and Treatments

King's College London
2016-2025

Wellcome Centre for Human Neuroimaging
2016-2025

Wellcome Trust
2021-2023

NIHR Maudsley Dementia Biomedical Research Unit
2013-2022

NIHR Maudsley Biomedical Research Centre
2013-2022

ORCID
2022

Imperial College London
2010-2020

Jagiellonian University
2020

South London and Maudsley NHS Foundation Trust
2020

King's College Hospital
2020

Abstract Objective: Patient outcome after traumatic brain injury (TBI) is highly variable. The underlying pathophysiology of this poorly understood, but inflammation potentially an important factor. Microglia orchestrate many aspects response. Their activation can be studied in vivo using the positron emission tomography (PET) ligand [11C](R)PK11195 (PK). In study, we investigate whether inflammatory response to TBI persists, and relates structural abnormalities cognitive function. Methods:...

10.1002/ana.22455 article EN Annals of Neurology 2011-04-18

This study identifies by microautoradiography activated microglia/macrophages as the main cell type expressing peripheral benzodiazepine binding site (PBBS) at sites of active CNS pathology. Quantitative measurements PBBS expression in vivo obtained PET and [11C](R)-PK11195 are shown to correspond animal experimental human post-mortem data on distribution pattern microglia inflammatory brain disease. Film autoradiography with [3H](R)-PK11195, a specific ligand for PBBS, showed minimal normal...

10.1093/brain/123.11.2321 article EN Brain 2000-11-01

Networks, as efficient representations of complex systems, have appealed to scientists for a long time and now permeate many areas science, including neuroimaging (Bullmore Sporns 2009 Nat. Rev. Neurosci. 10 , 186–198. ( doi:10.1038/nrn2618 )). Traditionally, the structure networks has been studied through their statistical properties metrics concerned with node link properties, e.g. degree-distribution, centrality modularity. Here, we study characteristics functional brain at mesoscopic...

10.1098/rsif.2014.0873 article EN cc-by Journal of The Royal Society Interface 2014-10-29

The functions of the resting state networks (RSNs) revealed by functional MRI remain unclear, but it has seemed possible that emerge in parallel with development related cognitive functions. We tested alternative hypothesis: full repertoire dynamics emerges during period rapid neural growth before normal time birth at term (around 40 wk gestation). used a series independent analytical techniques to map detail different 70 infants born between 29 and 43 postmenstrual age (PMA). characterized...

10.1073/pnas.1007921107 article EN Proceedings of the National Academy of Sciences 2010-11-01

<b>Background:</b> Patients with amnestic mild cognitive impairment (MCI) represent an important clinical group as they are at increased risk of developing Alzheimer disease (AD). <sup>11</sup>C-PIB PET is in vivo marker brain amyloid load. <b>Objective:</b> To assess the rates conversion MCI to AD during a 3-year follow-up period and compare levels deposition between converters nonconverters. <b>Methods:</b> Thirty-one subjects baseline PET, MRI, neuropsychometry have been clinically...

10.1212/wnl.0b013e3181b23564 article EN Neurology 2009-07-09

Huntington disease (HD) is characterized by the progressive death of medium spiny dopamine receptor bearing striatal GABAergic neurons. In addition, microglial activation in areas neuronal loss has recently been described postmortem studies. Activated microglia are known to release neurotoxic cytokines, and these may contribute pathologic process.To evaluate vivo involvement HD, authors studied patients at different stages using [(11)C](R)-PK11195 PET, a marker activation, [(11)C]raclopride...

10.1212/01.wnl.0000222734.56412.17 article EN Neurology 2006-06-12

Objective: The purpose of this study was to determine whether microglial activity, measured using translocator-protein positron emission tomography (PET) imaging, is increased in unmedicated persons presenting with subclinical symptoms indicating that they are at ultra high risk psychosis and activity elevated schizophrenia after controlling for a translocator-specific genetic polymorphism. Method: authors used the second-generation radioligand [11C]PBR28 PET image brains participants...

10.1176/appi.ajp.2015.14101358 article EN American Journal of Psychiatry 2015-10-16

Activated microglia may play a role in the pathogenesis of Alzheimer disease (AD) as they cluster around beta-amyloid (Abeta) plaques. They are, therefore, potential therapeutic target both AD and its prodrome amnestic mild cognitive impairment (MCI).To characterize vivo with (11)C-(R)-PK11195 (11)C-PIB PET distribution microglial activation amyloid deposition patients MCI.Fourteen subjects MCI had psychometric tests.Seven out 14 (50%) increased cortical retention (p < 0.001) while 5 13...

10.1212/01.wnl.0000338622.27876.0d article EN Neurology 2009-01-02

Objective: While there is robust evidence of elevated dopamine synthesis capacity once a psychotic disorder has developed, little known about whether it altered prior to the first episode frank illness. The authors addressed this issue by measuring in individuals at ultra-high risk psychosis and then following them determine their clinical outcome. Method: This prospective study included 30 patients who met standard criteria for being 29 healthy volunteers. Participants were scanned using...

10.1176/appi.ajp.2011.11010160 article EN American Journal of Psychiatry 2011-07-19

Levodopa-induced dyskinesias (LIDs) are the most common and disabling adverse motor effect of therapy in Parkinson's disease (PD) patients. In this study, we investigated serotonergic mechanisms LIDs development PD patients using 11C-DASB PET to evaluate serotonin terminal function 11C-raclopride dopamine release. with showed relative preservation terminals throughout their disease. Identical levodopa doses induced markedly higher striatal synaptic concentrations compared stable responses...

10.1172/jci71640 article EN Journal of Clinical Investigation 2014-02-16

The dopamine hypothesis suggests that abnormalities underlie psychosis, irrespective of diagnosis, implicating dysregulation in bipolar affective disorder and schizophrenia, line with the research domain criteria approach. However, this has not been directly examined individuals diagnosed psychosis.

10.1001/jamapsychiatry.2017.2943 article EN cc-by JAMA Psychiatry 2017-10-19

Quantitative in vivo imaging of myelin loss and repair patients with multiple sclerosis (MS) is essential to understand the pathogenesis disease evaluate promyelinating therapies. Selectively binding central nervous system white matter, Pittsburgh compound B ([11 C]PiB) can be used as a positron emission tomography (PET) tracer explore dynamics MS.Patients active relapsing-remitting MS (n = 20) healthy controls 8) were included longitudinal trial combining PET [11 C]PiB magnetic resonance...

10.1002/ana.24620 article EN cc-by Annals of Neurology 2016-02-19

Resistance to antipsychotic treatment is a significant clinical problem in patients with schizophrenia approximately 1 3 showing limited or no response repeated treatments medication. The neurobiological basis for resistance unknown but recent evidence implicates glutamatergic function the anterior cingulate cortex. We examined glutamate levels of chronically ill treatment-resistant directly compared treatment-responsive patients.We acquired proton magnetic resonance spectroscopy (1H-MRS) at...

10.1093/schbul/sbv151 article EN Schizophrenia Bulletin 2015-12-17
Renzo Mancuso Gemma L. Fryatt Madeleine Cleal Juliane Obst Elena Pipi and 95 more Jimena Monzón‐Sandoval Elena M. Ribé Laura Winchester Caleb Webber Alejo Nevado‐Holgado Tom Jacobs Nigel Austin Clara Theunis Karolien Grauwen Eva Ruiz Amritpal Mudher Marta Vicente‐Rodríguez Christine A. Parker Camilla Simmons Diana Cash Jill Richardson Edward T. Bullmore Junaid Bhatti Samuel J Chamberlain Marta Correia Anna Crofts Amber Dickinson Andrew C Foster Manfred G. Kitzbichler Clare Knight Mary-Ellen Lynall Christina Maurice Ciara O’Donnell Linda Pointon Peter St George‐Hyslop Lorinda Turner Petra E. Vértes Barry Widmer Guy Williams B. Paul Morgan Claire A. Leckey Angharad R. Morgan Caroline O’Hagan Samuel Touchard Jonathan Cavanagh Catherine Deith Scott Farmer John McClean Alison McColl Andrew McPherson Paul Scouller Murray Sutherland H.W.G.M. Boddeke Jill Richardson Shahid A. Khan Phil Murphy Christine A. Parker Jai Patel Declan N.C. Jones Peter de Boer John A. Kemp Wayne C. Drevets Jeffrey S. Nye Gayle Wittenberg John Isaac Anindya Bhattacharya Nick Carruthers Hartmuth C. Kolb Carmine M. Pariante Federico Turkheimer Gareth J. Barker Heidi Byrom Diana Cash Annamaria Cattaneo Antony D. Gee Caitlin Hastings Nicole Mariani Anna McLaughlin Valeria Mondelli Maria Antonietta Nettis Naghmeh Nikkheslat Karen Randall Hannah Sheridan Camilla Simmons Nisha Singh Victoria Van Loo Marta Vicente‐Rodríguez Tobias C. Wood Courtney Worrell Zuzanna Zajkowska Niels Plath Jan Egebjerg Hans Eriksson François Gastambide Karen Husted Adams Ross Jeggo Christian Thomsen Jan Pederson Brian Campbell T. Möller

Neuroinflammation and microglial activation are significant processes in Alzheimer's disease pathology. Recent genome-wide association studies have highlighted multiple immune-related genes with disease, experimental data demonstrated proliferation as a component of the neuropathology. In this study, we tested efficacy selective CSF1R inhibitor JNJ-40346527 (JNJ-527) P301S mouse tauopathy model. We first anti-proliferative effects JNJ-527 on microglia ME7 prion model, its impact inflammatory...

10.1093/brain/awz241 article EN cc-by Brain 2019-07-24

A crucial challenge in neuroscience involves characterising brain dynamics from high-dimensional recordings. Dynamic Functional Connectivity (dFC) is an analysis paradigm that aims to address this challenge. dFC consists of a time-varying matrix (dFC matrix) expressing how pairwise interactions across areas change over time. However, the main approaches have been developed and applied mostly empirically, lacking common theoretical framework clear view on interpretation results derived...

10.1371/journal.pcbi.1012795 article EN cc-by PLoS Computational Biology 2025-03-07

There is general agreement that, after initial processing in unimodal sensory cortex, the pathways for spoken and written language converge to access verbal meaning. However, existing literature provides conflicting accounts of cortical location this convergence. Most aphasic stroke studies localize comprehension posterior temporal inferior parietal cortex (Wernicke’s area), whereas evidence from focal neurodegenerative syndromes instead implicates anterior cortex. Previous functional...

10.1523/jneurosci.0559-06.2006 article EN cc-by-nc-sa Journal of Neuroscience 2006-07-12
Coming Soon ...